Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
Condition: Efficacy and Safety Interventions: Drug: Rituximab combined with tacrolimus induction + rituximab maintenance; Drug: Rituximab combined with tacrolimus induction + tacrolimus maintenance; Drug: Glucocorticoid combined with cyclophosphamide induction + maintenance Sponsor: RenJi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials